Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 6.32 | N/A |
| PEG Ratio (TTM) | 0.98 | N/A |
| P/S Ratio (TTM) | 0.74 | N/A |
| P/B Ratio (TTM) | 0.88 | N/A |
| P/FCF Ratio (TTM) | -4.90 | N/A |
| Price to 5YR AVG Earnings Ratio | 1.50 | N/A |
| Price to 5YR AVG FCF Ratio | 4.36 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.98% | N/A |
| ROE (TTM) | 14.37% | N/A |
| Net Profit Margin (TTM) | 11.39% | N/A |
| ROIC 5YR AVG | 20.97% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.01% | 9.91% | 14.18% |
| Revenue | 4.46% | 37.14% | 32.41% |
| Net Income | 6.88% | 11.68% | 14.80% |
| Cash Flow | -18.74% | 137.42% | 141.99% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.52 | N/A |
| Quick Ratio (TTM) | 1.52 | N/A |
| D/E Ratio (TTM) | 0.21 | N/A |
| Interest Coverage (TTM) | 1.77 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.12 | N/A |
| LTL to 5YR AVG FCF | 10.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.41% | N/A |